Promising study on low-salt fasting-mimicking diet for chronic kidney disease
Forays into the growing nutritional wellness space
Mumbai-based pharmaceutical firm Cipla has announced that Cipla Health, a wholly owned subsidiary and consumer healthcare arm of the company has signed definitive agreements for acquisition of Endura Mass, a renowned nutritional supplement brand in the category of weight gain from Medinnbelle Herbalcare Private Limited. Endura and all other associated trademarks would be part of the acquisition.
This acquisition is in line with Cipla’s strategic imperative to augment the company’s wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Commenting on the development, Shivam Puri, Chief Executive Officer, Cipla Health said, “With this strategic acquisition, we will be expanding our portfolio into a new category of weight gain, thereby catering to a very specific nutritional need for a set of our consumers. Being underweight is linked to multiple challenges such as poor stamina, poor concentration and low immunity. The addition of Endura & Endura mass to our portfolio perfectly complements our existing offerings across all key OTC/Wellness categories and would hence help us offer an even more comprehensive solution to all key consumer needs.”